Brief: Xilio Therapeutics Q3 Net Income USD -16.748 Million
09/11/2023 21:01
Nov 09 (Reuters) - Xilio Therapeutics Q3 income from operations USD -17.361 million. * Q3 basic EPS USD -0.61 * Q3 operating expenses USD 17.361 million
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla